No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
EVH240816P17500
- 0.49
- 0.000.00%
15min DelayTrading Jul 19 11:56 ET
0.00High0.00Low
0.00Open0.49Pre Close0 Volume21 Open Interest17.50Strike Price0.00Turnover61.09%IV12.18%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.49Extrinsic Value100Contract SizeAmericanOptions Type-0.2447Delta0.1011Gamma39.53Leverage Ratio-0.0186Theta-0.0033Rho-9.67Eff Leverage0.0160Vega
Intraday
- 5D
- Daily
News
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
Trending Stocks Today: Shimmick Surges 46.85% Post-Market
July 16th - US stocks trending post-market.Gainers: $Shimmick(SHIM.US)$ shoots up 46.85% to $3.04 with a turnover of $7.02 million. $Aehr Test Systems(AEHR.US)$ rises 12.64% to $18.97 with a
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist
Press Release: Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire WASHINGTON, July 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON, July 11, 2024 /
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63
TD Cowen analyst Charles Rhyee maintains $Evolent Health(EVH.US)$ with a buy rating, and maintains the target price at $63.According to TipRanks data, the analyst has a success rate of 46.7% and a
TD Cowen Sticks to Its Buy Rating for Evolent Health (EVH)
Comments
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
7
Russell Glass joining the Board of Directors is viewed positively due to his vast experience in healthcare services, tech, and AI. His addition could bring crucial depth in healthcare tech innovation to Evolent.
1
Upgrades
• $New Oriental(EDU.US$ : BofA Securities Upgrades to Buy from Neutral - PT $36.60 (from $18.80)
• $ExlService(EXLS.US$ : Needham Upgrades to Buy from Hold - PT $190
• $First Solar(FSLR.US$ : Oppenheimer Upgrades to Outperform from Perform
• $Mid-America Apartment Communities Inc(MAA.US$ : JMP Securities Upgrades to Market Outperform from Market Perform - PT $220
• $Northrop Grumman(NOC.US$ : Baird Upgrades to Outp...
• $New Oriental(EDU.US$ : BofA Securities Upgrades to Buy from Neutral - PT $36.60 (from $18.80)
• $ExlService(EXLS.US$ : Needham Upgrades to Buy from Hold - PT $190
• $First Solar(FSLR.US$ : Oppenheimer Upgrades to Outperform from Perform
• $Mid-America Apartment Communities Inc(MAA.US$ : JMP Securities Upgrades to Market Outperform from Market Perform - PT $220
• $Northrop Grumman(NOC.US$ : Baird Upgrades to Outp...
15
1
$Boeing(BA.US$ Boeing said that the U.S. Department of Defense has awarded it a follow-up contract worth 23.8 billion U.S. dollars to provide 10-year service for the C-17 transport aircraft. It is reported that Boeing will continue to provide engineering, field support and materials management services for 275 aircraft of the U.S. Air Force and eight global partners
$Walgreens Boots Alliance(WBA.US$ $Evolent Health(EVH.US$ It is reported that Walgreens Boots Alliance is weighing the acquisition of Evolent Health, a provider of medical insurance services.
$Robinhood(HOOD.US$ Robinhood said it has established a content partnership with Snapchat to bring "Snacks" financial content services to Snapchat's mobile users
$Walgreens Boots Alliance(WBA.US$ $Evolent Health(EVH.US$ It is reported that Walgreens Boots Alliance is weighing the acquisition of Evolent Health, a provider of medical insurance services.
$Robinhood(HOOD.US$ Robinhood said it has established a content partnership with Snapchat to bring "Snacks" financial content services to Snapchat's mobile users
3
Read more